老年乳腺癌幸存者监测性乳腺X线摄影专家共识指南配套患者指南的可接受性
研究创建了「乳腺X线摄影还适合我吗?」患者指南,在国立癌症研究所指定的综合癌症中心(含两个社区诊所)对45例老年乳腺癌幸存者及21名临床医生进行诊室内可接受性测试。诊后调查中33/37(89%)患者和15/16(94%)医生愿意向他人推荐该指南,所有预设可接受性标准均达到。结论认为该指南可接受且清晰,需多中心临床试验评估其对乳腺X线摄影利用的影响。
要点
- 该指南面向≥75岁或预期寿命<10年的乳腺癌幸存者,用于辅助监测性乳腺X线摄影的共享决策。
- 诊后调查中33/37(89%)患者和15/16(94%)医生愿意推荐该指南。
- 多数患者报告强烈的乳腺X线摄影意愿(诊前100%,诊后98%)。
核心结论
- 肿瘤科临床医生和老年乳腺癌幸存者认为该指南可接受且清晰,需要多中心临床试验评估其对乳腺X线摄影利用的影响。
研究设计与样本
- 在国立癌症研究所指定的综合癌症中心(含两个社区诊所)进行的诊室内可接受性测试,纳入45例患者及其21名临床医生,患者在诊前和诊后接受调查、临床医生在诊后接受调查。
诊断标准与关键数值
- 可接受性定义为≥75%的患者和临床医生报告该指南(a)应向他人推荐、(b)清晰、(c)有帮助、(d)包含适量信息;诊后调查中33/37(89%)患者和15/16(94%)医生愿意推荐,33/37(89%)患者和15/16(94%)医生认为全部/大部分内容清晰。
临床应用与阅片要点
- 该指南估算未来同侧和对侧乳腺(乳腺内)癌症风险、总体健康及乳腺X线摄影的潜在获益/危害,并附讨论提示。
- 作者结论认为该指南可接受且清晰,需多中心临床试验评估其对乳腺X线摄影利用的影响。
局限性
- 需要多中心临床试验评估该指南对乳腺X线摄影利用的影响。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
PURPOSE: To support shared decision-making, patient-facing resources are needed to complement recently published guidelines on approaches for surveillance mammography in breast cancer survivors aged ≥ 75 or with < 10-year life expectancy. We created a patient guide to facilitate discussions about surveillance mammography in older breast cancer survivors.
METHODS: The "Are Mammograms Still Right for Me?" guide estimates future ipsilateral and contralateral breast (in-breast) cancer risks, general health, and the potential benefits/harms of mammography, with prompts for discussion. We conducted in-clinic acceptability testing of the guide by survivors and their clinicians at a National Cancer Institute-designated comprehensive cancer center, including two community practices. Patients and clinicians received the guide ahead of a clinic visit and surveyed patients (pre-/post-visit) and clinicians (post-visit). Acceptability was defined as ≥ 75% of patients and clinicians reporting that the guide (a) should be recommended to others, (b) is clear, (c) is helpful, and (d) contains a suitable amount of information. We also elicited feedback on usability and mammography intentions.
RESULTS: We enrolled 45 patients and their 21 clinicians. Among those responding in post-visit surveys, 33/37 (89%) patients and 15/16 (94%) clinicians would recommend the guide to others; 33/37 (89%) patients and 15/16 (94%) clinicians felt everything/most things were clear. All other pre-specified acceptability criteria were met. Most patients reported strong intentions for mammography (100% pre-visit, 98% post-visit).
CONCLUSION: Oncology clinicians and older breast cancer survivors found a guide to inform mammography decision-making acceptable and clear. A multisite clinical trial is needed to assess the guide's impact mammography utilization.
TRIAL REGISTRATION: ClinicalTrials.gov-NCT03865654, posted March 7, 2019.
引用
- Freedman, Revette, Gagnon, et al. Acceptability of a companion patient guide to support expert consensus guidelines on surveillance mammography in older breast cancer survivors. Breast Cancer Res Treat. 2022. PMID: 35908120. doi:10.1007/s10549-022-06676-3
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。